Abstract
To determine the effects of hepatitis G virus(HGV) infection on chronic hepatitis C virus infection(HCV) and to evaluate HGV response to interferon, weinvestigated HGV RNA by polymerase chain reaction in 247 Japanese patients with chronic HCVinfection (166 men and 81 women; 124 had chronichepatitis and 26 cirrhosis, and 97 hepatocellularcarcinoma). HGV RNA was detectable in 22 (8.9%)patients, among whom 21 were men: this male predominance wasstatistically significant (P < 0.01). The re were nodifferences in age, aminotransferase level, stage ofliver disease, HCV RNA level by competitive polymerase chain reaction, genotype, or interferonresponse to HCV RNA between patients with HCV infectionalone or with HCV/HGV coinfection. Sustained eliminationof HGV RNA was found in 28.6% of the 14 treated patients with HCV/HGV coinfection. In the 14 treatedpatients, sustained elimination of both viruses was seenin two, HCV alone was eliminated in two, and HGV alonewas eliminated in two. Aminotransferase level improvement by interferon treatment wasassociated with clearance of HCV, but not of HGV. Thus,HGV infection had no apparent effects on HCV infection,and the sensitivity of HGV to interferon is comparable to but independent of HCV.
Similar content being viewed by others
REFERENCES
Simons JN, Leary TP, Dawnson GJ, Pilot-Matias TJ, Muerhoff AS, Schlauder GG, Desai SM, Mushahwar IK: Isolation of novel virus-like sequences associated with human hepatitis.Nat Med 1:564-569, 1995
Linnen J, Wages Jr J, Zhang-Keck ZY, Fry KE, Krawczynski KZ, Alter H, Koonin E, Gallagher M, Alter M, Hadziannis S, Karayiannis P, Fung K, Nakatsuji Y, Shih J W-K, Young L, Piatak Jr M, Hoover C, Fernandez J, Chen S, Zou J-C, Morris T, Hyams K, Ismay S, Lifson JD, Hess G, Foung SKH, Thomas H, Bradley D, Margolis H, Kim JP: Molecularcloning and disease association of hepatitis G virus: A transfusiontransmissible agent. Science 271:505-508, 1996
Alter HJ, Nakatsuji Y, Melpolder J, Wages J, Wesley R, Shih JWK, Kim JP: The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. N Engl J Med 336:747-754, 1997
Stark K, Bienzle U, Hess G, Engel AM, Hegenscheid B, Schluter V: Detection of the hepatitis G virus genome among injecting drug users, homosexual and bisexual men, and blood donors. J Infect Dis 174:1320-1323, 1996
Masuko K, Mitsui T, Iwano K, Yamazaki C, Okuda K, Meguro T, Murayama N, Inoue T, Tsuda F, Okamoto H, Miyakawa Y, Mayumi M: Infection with hepatitis GB virus C in patients on maintenance hemodialysis. N Engl J Med 334:1485-1490, 1996
Tsuda F, Hadiwandowo S, Sawada N, Fukuda M, Tanaka T, Okamoto H, Miyakawa Y, Mayumi M: Infection with GB virus C (GBV-C) in patients with chronic liver disease or on maintenance hemodialysis in Indonesia. J Med Virol 49:248-252,1996
Wu JC, Sheng WY, Huang YH, Hwang SJ, Lee SD: Prevalence and risk factor analysis of GBV-C/HGV infection in prostitutes. J Med Virol 52:83-85, 1997
Yoshiba M, Okamoto H, Mishiro S: Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology. Lancet 346:1131-1132, 1995
Hayashi J, Kishihara Y, Yamaji K, Furusyo N, Yamamoto T, Pae Y, Etoh Y, Ikematsu H, Kashiwagi S: Hepatitis C virus quasispecies and liver damage in patients with chronic hepatitis C virus infection. Hepatology 25:697-701, 1997
Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, Tanaka T, Sato K, Tsuda F, Miyakawa Y, Mayumi M: Typing hepatitis C virus by polymerase chain reaction with type-specific primers: Application to clinical surveys and tracing infectious sources. J Gen Virol 73:673-679, 1992
Simmonds P, Alberti A, Alter HJ, Bonino F, Bradley DW, Brechot C, Brouwer JT, Chan SW, Chayama K, Chen DS, Choo QL, Colombo M, Cuypers TM, Date T, Dusheiko GM, Esteban JI, Fay O, Hadziyannis SJ, Han J, Hatzakis A, Holmes EC, Hotta H, Houghton M, Irvine B, Kohara M, Kolberg JA, Kuo G, Lau JYN, Lelie PN, Maertens G, McOmish F, Miyamura T, Mizokami M, Nomoto A, Prince AM, Reesink HW, Rice C, Roggendorf M, Schalm SW, Shikata T, Shimotohno K, Stuyver L, Trepo C, Weiner A, Yap PL, Urdea MS: A proposed system for nomenclature of genotypes for hepatitis C virus. Hepatology 19:1321-1324, 1994
Kato N, Yokosuka O, Hosoda K, Ito Y, Ohto M, Omata M:Quantitative of hepatitis C virus competitive reverse transcription-polymerase chain reaction: Increase of the virus in advanced liver disease. Hepatology 18:16-20, 1993
Inoue T, Sakamoto M, Akahane Y, Okamoto H, Miyakawa Y, Mayumi M: Response to interferon of GB virus C and hepatitis C virus in patients with chronic hepatitis. Am J Gastroenterol 92:1981-1985, 1997
Francesconi R, Giostra F, Ballardini G, Manzin A, Solforosi L, Lari F, Descovich C, Ghetti S, Grassi A, Bianchi G, Zauli D, Clementi M, Bianchi FB: Clinical implications of GBV-C/ HGV infection in patients with "HCV-related" chronic hepatitis. J Hepatol 26:1165-1172, 1997
Hayashi J, Furusyo N, Sawayama Y, Kishihara Y, Kawakami Y, Ariyama I, Etoh Y, Kashiwagi S: Hepatitis G virus in the general population and in patients on hemodialysis. Dig Dis Sci 43:2143-2148, 1998
Kashiwagi S, Hayashi J, Ikematsu H, Nomura H, Kusaba T, Shingu T, Hayashida K, Kaji M: An epidemiologic study of hepatitis B virus in Okinawa and Kyushu, Japan. Am J Epidemiol 118:787-794, 1983
Hayashi J, Kishihara Y, Yamaji K, Yoshimura E, Kawakami Y, Akazawa K, Kashiwagi S: Transmission of hepatitis C virus by health care workers in a rural area of Japan. Am J Gastroenterol 90:794-799, 1995
Tacke M, Kiyosawa K, Stark K, Schlueter V, Ofenloch-Haehnle B, Hess G, Engel AM: Detection of antibodies to putative hepatitis G virus envelope protein. Lancet 349:318-320, 1997
Tanaka E, Alter HJ, Nakatsuji Y, Shih JWK, Kim JP, Matsumoto A, Kobayashi M, Kiyosawa K: Effect of hepatitis G virus infection on chronic hepatitis C. Ann Intern Med 125:740-743,1996
Kubo S, Nishiguchi S, Kuroki T, Hirohashi K, Tanaka H, Tsukamoto T, Shuto T, Kinoshita H: Poor association of GBV-C viremia with hepatocellular carcinoma. J Hepatol 27:91-95, 1997
Hayashi J, Kishihara Y, Ueno K, Yamaji K, Kawakami Y, Furusyo N, Sawayama Y, Kashiwagi S: Age-related response to interferon alfa treatment in women vs men with chronic hepatitis C virus infection. Arch Intern Med 158:177-181, 1988
Alberti A, Pontisso P, Chemello L, Fattovich G, Benvegnu L, Belussi F, DeMitri MS: The interaction between hepatitis B virus and hepatitis C virus in acute and chronic liver disease.J Hepatol 22( suppl):38-41, 1995
Guidotti LG, Borrow P, Hobbs MV, Matzke B, Gresser I, Oldstone MBA, Chisari FV: Viral cross talk: Intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver. Proc Natl Acad Sci USA 93:4589-4594,1996
VanThiel DH, Caraceni P, Molloy PJ, Hassanein T, Kania RJ, Gurakar A, Friedlander L: Chronic hepatitis C in patients with normal or near normal alanine aminotransferase levels: The role of interferon a2b Therapy. J Hepatol 23:503-508, 1995
Wong DK, Cheung AM, O'Rourke, Naylor CD, Detsky AS, Heathcote J: Effect of alpha-interferon treatment in patients with hepatitis Be antigen-positive chronic B: A meta-analysis.Ann Intern Med 119:312-323, 1993
Rights and permissions
About this article
Cite this article
Hayashi, J., Ueno, K., Kawakami, Y. et al. Clinical Course of Chronic Hepatitis C Virus Infection Is Not Influenced by Concurrent Hepatitis G Virus Infection. Dig Dis Sci 44, 618–623 (1999). https://doi.org/10.1023/A:1026677912187
Issue Date:
DOI: https://doi.org/10.1023/A:1026677912187